Brief: Ultimovacs Starts Clinical Evaluation Of Novel Tet-Platform
18/02/2021 07:17
Feb 18 (Reuters) - Ultimovacs ASA ULTIMO.OL :
* ULTIMOVACS STARTS CLINICAL EVALUATION OF NOVEL
TET-PLATFORM WITH
PHASE I
Source text for Eikon: ID:nObitN1cBa
Further company coverage: ULTIMO.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Zelluna ASA
See all newsNorway's Zelluna ASA reports Q2 loss
Brief: Zelluna Reports Q2 Total Loss Of NOK 19.7 Million
Brief: Zelluna Says IDMC Recommends Recruitment Of Next Two Patients At First Dose Level
Brief: Zelluna Says First Patient Dosed With Zi-Ma4-1 In Zima-101 Phase 1 Trial
Brief: Zelluna Wins NOK 16 Mln Research Council Of Norway Grant